Second-order partial correlation analysis of sectoral water use in China from 2005 to 2022. by Jianqin Ma (20328414)

Subjects:

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

Subjects:

The comparisons of key properties for different ZrO₂-doped fabricated composites. by Md. Abu Daud (21485629)

Subjects:

Effect of ZrO₂ Addition on CTE. by Md. Abu Daud (21485629)

Subjects:

The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

“…<i>n</i> = 2–4 biological replicates per condition, with 15 individuals per replicate. Significance levels for Student <i>t</i> test are indicated for adjusted <i>p</i> values: *<i>p</i> < 0.05, ***<i>p</i> < 0.001, ***<i>p</i> < 0.0001. d: day(s), n.s.: non-significant. …”

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…HRQoL outcome was assessed with the 5-level version of the EuroQol (EQ-5D-5L) instrument at baseline (pre-injury) and at 2, 4, 6, and 12 months post-injury. …”

Feeding and starvation affect the proportion and cell cycle activity of Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

S1 Dataset - by Yue He (385239)

“…With the gradual exposure of CS, sRAGE expression gradually decreased, and was significantly reduced after COPD formation compared with the control group.…”

(a to g) Administration of vitamin D3 increased serum phosphorus and triglycerides. by Vidya G. Bettada (22208808)

“…Analyses of serum cholesterol, HDL and triglycerides also showed a non-significant decrease in the serum HDL level upon treatment with 125 µg/Kg vitamin D3, but a noticeable increase in the serum triglyceride level was observed with 125 µg/Kg of vitamin D3.…”

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: by Vidya G. Bettada (22208808)

“…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…”

CaSki cells functionally express VDR and RXR. by Euclides Avila (41023)

Subjects:

Biological processes activated and suppressed, along with associated genes, induced by calcitriol treatment in CaSki cervical cancer cells. by Euclides Avila (41023)

Subjects:

Calcitriol inhibits CaSki cell migration and suppresses MMP7 and MMP13 gene expression. by Euclides Avila (41023)

Subjects:

Differentially expressed mature microRNAs in CaSki cells modulated by calcitriol, with fold change thresholds of ≥ 1.5 or ≤ -1.5. by Euclides Avila (41023)

Subjects:

Validation of gene expression changes induced by calcitriol in CaSki cells. by Euclides Avila (41023)

Subjects:

A complete list of differentially expressed genes by calcitriol was compared with vehicles in CaSki cervical cancer cells. by Euclides Avila (41023)

Subjects:

Oligonucleotide sequences and hydrolysis probes used in this study. by Euclides Avila (41023)

Subjects:

Uncropped original figures from the western blot experiments presented in this article. by Euclides Avila (41023)

Subjects:

Heatmaps of the top 536 differentially expressed genes (DEG) by calcitriol in CaSki cells with fold changes ranging from 1.5 to −1.5. by Euclides Avila (41023)

Subjects:

Predicted interaction network of differentially expressed genes by calcitriol in CaSki cervical cancer cells. by Euclides Avila (41023)

Subjects: